Document type
ArticleVersion
Published versionPublication date
Publication license
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/214813
In vivo photocontrol of orexin receptors with a nanomolar light-regulated analogue of orexin-B
Journal Title
Director/Tutor
Journal ISSN
Volume Title
Related resource
Abstract
Orexinergic neurons are critically involved in regulating arousal, wakefulness, and appetite. Their dysfunction has been associated with sleeping disorders, and non-peptide drugs are currently being developed to treat insomnia and narcolepsy. Yet, no light-regulated agents are available to reversibly control their activity. To meet this need, a photoswitchable peptide analogue of the endogenous neuroexcitatory peptide orexin-B was designed, synthesized, and tested in vitro and in vivo. This compound – photorexin – is the first photo-reversible ligand reported for orexin receptors. It allows dynamic control of activity in vitro (including almost the same efficacy as orexin-B, high nanomolar potency, and subtype selectivity to human OX2 receptors) and in vivo in zebrafish larvae by direct application in water. Photorexin induces dose- and light-dependent changes in locomotion and a reduction in the successive induction reflex that is associated with sleep behavior. Molecular dynamics calculations indicate that trans and cis photorexin adopt similar bent conformations and that the only discriminant between their structures and activities is the positioning of the N-terminus. This, in the case of the more active trans isomer, points towards the OX2 N-terminus and extra-cellular loop 2, a region of the receptor known to be involved in ligand binding and recognition consistent with a “message-address” system. Thus, our approach could be extended to several important families of endogenous peptides, such as endothelins, nociceptin, and dynorphins among others, that bind to their cognate receptors through a similar mechanism: a “message” domain involved in receptor activation and signal transduction, and an “address” sequence for receptor occupation and improved binding affinity.
Subject
Subject (English)
Citation
Citation
PRISCHICH, Davia, et al. In vivo photocontrol of orexin receptors with a nanomolar light-regulated analogue of orexin-B. Cellular And Molecular Life Sciences. 2024. Vol. 81, num. 1. ISSN 1420-9071. [consulted: 9 of August of 2026]. Available at: https://hdl.handle.net/2445/214813